UNSPSC 41202049: Rabiesvirus immunofluorescent reagents

In this classification, Rabiesvirus immunofluorescent reagents are devices used in test to identify specific Rabiesvirus immunofluorescent reagents antibodies in serum. US FDA regulates Rabiesvirus immunofluorescent reagents under 21 CFR 866.3460 and under FDA product code GOI.

UNSPSC 41202049 Rabiesvirus immunofluorescent reagents is a Commodity code that does not align with recent state and local solicitation activity. The code nominally covers rabies diagnostic reagents, but the recent opportunities block contains no procurements for rabies testing materials. Instead, the nine most recent state and local solicitations tagged to this code address HIV testing kits, syphilis reagents, hepatitis screening assays, forensic laboratory services (urine and feces analysis), drug and specimen screening services, and pool maintenance — none of which are rabies-related. The mismatch appears systematic: multiple Illinois Department of Public Health, Texas Department of Criminal Justice, City of Austin, and Collin County solicitations center on HIV and syphilis diagnostics, which fall under different UNSPSC commodity classifications. The code shows no relevant recent activity for the product category it nominally describes.

The geographic spread of the mistagged solicitations spans Texas (Collin County, Austin, TDCJ statewide), Illinois (IDPH and state-level procurements), and Florida (Collier County pool maintenance). Issuing bodies include state health departments (Illinois IDPH), state criminal-justice agencies (Texas TDCJ), county supervision and corrections departments (Collin County), municipalities (City of Austin), higher education (University of Houston), and county parks and recreation divisions (Collier County). Representative recent opportunities include Collin County's RFP 2026-327 for offender specimen collection and drug testing services (response due July 23, 2026, estimated contract value $600,000), the City of Austin's IFB 9100AAM1023 for rapid HIV test kits (response due July 17, 2026), and the Illinois Department of Public Health's IFB 26482DPHOFCDIB50489 for hepatitis, HIV, and syphilis screening assays and instrumentation (response due March 16, 2026). The code designation does not support meaningful business development activity under its stated rabies-immunofluorescent-reagent scope.